Purpose: The Amblyopia tracker app has been developed to be a tool for parents to monitor changes in vision at home during amblyopia treatment. The aims of this study were to evaluate the feasibility and repeatability of parents testing their children at home and to compare home test results to an assessment in clinic by an orthoptist.
Methods: Children (age < 18 years) with amblyopia (interocular acuity difference of ≥ 0.
Purpose: A new amblyopia tracker app has been designed to provide parents with a method of monitoring a child's vision by presenting a single optotype size that the tester moves to identify the furthest distance the optotypes can be seen. The aim of this study is to evaluate this methodology in adults, comparing the findings to visual acuity (VA) measured with the iSight app and to determine the test retest variability.
Methods: Adults, aged 18-39 years, with no known eye condition and VA ≤ 0.
Objective: To determine whether the mortality in a cohort of patients with psoriatic arthritis (PsA) from a single center in the UK is significantly different from the general UK population.
Methods: Patients who were entered onto the PsA database at the Royal National Hospital for Rheumatic Diseases, Bath, between 1985 and 2007 were included in this study. Information on patient deaths was collected retrospectively.
Background: The discrepancy between the occurrence of disease and the risk of consulting a doctor is well known, but whether or not it is socially governed is uncertain and could have important implications for primary care manpower and resource allocation. The aim of the study was to investigate whether (i) reported occurrence of common symptoms in infancy and (ii) consulting rates for those symptoms, are associated with socio-economic status as marked by Council Tax Valuation Band (CTVB).
Methods: Compound cross-sectional analysis of data was obtained from sequential parental questionnaires.
Objective: The evaluation of a community-based exercise and education scheme for stroke survivors.
Design: A single blind parallel group randomized controlled trial.
Setting: Leisure and community centres in the south-west of England.